Active substance: Framicetin
ATX Code: R01AX08
KFH: Antibacterial drug for topical application in ENT practice
ICD-10 codes (readings): J00, J01, J31, J32, Z29.2, Z29.8
CFU Code: 06.05.04
Manufacturer: Laboratoires BOUCHARA-RECORDATI (France)
DRUGS FORM, COMPOSITION AND PACKAGING
|Spray nasal 1.25%||1 ml|
|framicetin sulfate||12.5 mg (8 thousand IU)|
Excipients: methyl parahydroxybenzoate, sodium chloride, citric acid, distilled water.
15 ml - polyethylene bottles (1) complete with a spray - packs cardboard.
Antibiotic from the group of aminoglycosides for topical application in otorhinolaryngology. It is bactericidal. Active with respect to Gram-positive and gram-negative bacteria that cause the development of infectious processes in the upper respiratory tract.
Studies of the pharmacokinetics of the preparation of Isophra have not been carried out due to low systemic absorption.
As part of combination therapy for infectious and inflammatory diseases of the upper respiratory tract, including:
- sinusitis (in the absence of damage to the septum);
Preventive maintenance and treatment of inflammatory processes after surgical interventions.
Adults Assign an 1 injection to each nostril 4-6 times / day.
Children prescribe by 1 injection into each nostril 3 times / day.
The average duration of therapy is 7 days.
When using the bottle should be kept in a vertical position.
Allergic reactions: in single cases - skin manifestations.
- Hypersensitivity to framicetin and other antibiotics from the group of aminoglycosides.
PREGNANCY AND LACTATION
Adequate and strictly controlled clinical studies of the safety of the use of Isofra during pregnancy and lactation (breastfeeding) were not carried out.
If the therapeutic effect is absent or weak during the course of 7 days of treatment, the drug must be discontinued.
Due to the low degree of absorption in the systemic blood flow, an overdose is unlikely.
Clinically significant interactions of the preparation with other medicines have not been identified.
TERMS OF RELEASE FROM PHARMACY
The drug is released by prescription.
TERMS AND CONDITIONS OF STORAGE
The drug should be stored at a temperature not higher than 25 ° C. Shelf life is 3 years.